Following the acquisition of the Inception 5 program, Versant plans to launch Pipeline Therapeutics, a successor company led by the same operating team and a broadened network of academic founders. Pipeline will build an expanded platform to identify the next generation of neuro-regenerative therapies.

https://www.businesswire.com/news/home/20180404005042/en/Inception-Neuroscience-Program-Acquired-Roche